Phase I-II

Altus and Althea pair up

Altus and Althea pair up

By Gregory Roumeliotis

Biopharmaceutical firm Altus has asked contract manufacturer Althea
to produce Phase III quantities of a crystallised formulation of
human growth hormone (hGH) which can be administered subcutaneously
weekly instead of daily.

Business booms for PPD

Business booms for PPD

By Kirsty Barnes

As global contract research spending remains robust, business is
booming for Pharmaceutical Product Development (PPD) as the US firm
reported a surge in sales, profits and new business for its second
quarter 2006.

Follow us

Product Innovations